LIBTAYO is a prescription medicine used to treat people with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI.

What is the schedule for infusions of LIBTAYO? LIBTAYO is an IV infusion (350 mg) given over 30 minutes. Treatment with LIBTAYO happens once every 3 weeks. Infusion reactions may happen while you are receiving the drug. Infusion reactions can …

LIBTAYO is a prescription medicine used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation.

LIBTAYO® (cemiplimab-rwlc) is a prescription IV infusion given for 30 minutes every 3 weeks. Review Important Safety Info & Full Prescribing Information including Med Guide.

The recommended dosage of LIBTAYO is 350 mg administered as an intravenous infusion over 30 minutes every 3 weeks until disease progression, unacceptable toxicity, or up to 24 months.

LIBTAYO is the first medicine approved by the Food and Drug Administration (FDA) to treat CSCC that has spread or cannot be cured by surgery or radiation. LIBTAYO is a type of immunotherapy called a programmed death receptor-1 (PD-1) inhibitor. LIBTAYO is not chemotherapy or radiation therapy.

LIBTAYO is a prescription medicine used to treat people with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI.

LIBTAYO patient brochure: In this brochure, you will find information about treatment with LIBTAYO and other helpful resources, including the LIBTAYO patient wallet card. LIBTAYO Surround® patient overview brochure: If you are eligible, LIBTAYO Surround may help you with financial support for LIBTAYO

LIBTAYO is an immunotherapy given through an infusion that may help your immune system recognize, attack, and kill the cancer cells. Your body might not attack cancer because the cancer cells have developed ways to avoid the immune system.

%PDF-1.6 %âãÏÓ 53 0 obj > endobj 71 0 obj >/Filter/FlateDecode/ID[269FEC65CF736FCF57B4AA2ACC41406A>07D62C97144946FC959049DD6B511FA0>]/Index[53 35]/Info 52 0 R ...